Please ENTER to search

← Back

Atropine Sulfate

Detailed information about Atropine Sulfate

CAS Number

5908-99-6

Category

Muscarinic antagonist

Regulatory Status

US DMF Assessment Completed & CEP Approved regulatory_status

CEP/EDMF

CEP [R1 CEP 2015-317- Rev 01] EDMF Available

Innovator Brand

ISOPTO ATROPINE

Therapeutic Area

Ophthalmology, Muscarinic antagonist

USDMF

#029605

Others

TGA Approved, EDMF Approved in Portugal Agency, Infarmed, DMF Approved in CFDA, China

Atropine Sulfate

Mechanism of Action

Atropine Sulfate is an antimuscarinic agent that works by blocking the muscarinic acetylcholine receptors in the smooth muscles, secretory glands, and the central nervous system. It competitively inhibits the action of acetylcholine, a neurotransmitter that activates the parasympathetic nervous system. This results in decreased parasympathetic activity, leading to effects such as increased heart rate, decreased salivation, dilated pupils, and bronchial muscle relaxation. Atropine Sulfate also crosses the blood-brain barrier, exerting central nervous system effects.

Uses

Atropine Sulfate is primarily used in the treatment of bradycardia (low heart rate), certain types of heart block, and to reduce salivation and bronchial secretions during surgery. It can also be used as an antidote for organophosphate poisoning, in eye examinations to dilate pupils, and for symptomatic relief of gastrointestinal disorders like hypermotility and spasticity.

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer's risk.

Footer Form Banner

Ready to discuss your needs with us?

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

Please enter a valid name (only alphabets and spaces allowed).
Please enter your organization name.
Please enter a valid work email address.
Please enter a valid phone number.
Please select your country.
Please enter your message.
You must agree to the privacy policy.